Cn / En

CM05136


CM05136

Key word胰腺癌, PDX, 体内药效,体外药效,免疫系统人源化,奥拉帕利, 奥沙利铂, 奥希替尼, 厄洛替尼, 吉西他滨, 曲美替尼, 顺铂, 依维莫司, 长春新碱, 紫杉醇,

Model Information

Model IDCM05136
Cancer Type胰腺癌
Cell Subtype腺癌
Differentiation中低分化
Collection SiteHead
Metastatic Site 
GradeIIB
TNM stagingpT1cN1Mx
IHC diagnosis

胰头部肿物免疫组化标记结果:CAM5.2(+) PMS2(90%+)? S-100P(部分+) ?MUC-5(+)

EA(-)? MSH6(10%+)? D2-40(淋巴管+,可见瘤栓)?? MUC-6(+)

PP(胰岛+)?? PD.1(-)??? FAP(间质+)??? CD4(肿瘤间部分淋巴细胞+)

CD34(血管+)? PDL.1(-)?? DPC4(-)??? CD8(瘤间部分淋巴细胞+)

MLH1(90%+)?? TopoⅡ(25%+)??? MUC-1(+)? CD20(肿瘤间极少数

Pathology diagnosis1、(胰头)低至中分化导管腺癌 pT1cN1Mx(AJCC 第八版) 2、慢性胆囊炎,
Clinical Treatment Records 

Model Data

Histopathological Images

 

Tumor growth curve

  

In vivo efficacy of SOCs

  
  
  
  

In vitro efficacy of SOCs